The truth is I don’t know any more than anybody else about the current BODs plans for the company. I am only going on what they say, and I trust what they say because I was most impressed with how they designed the VF001 trial (even though the results weren’t the to our liking). I think they are very professional.
They say they HOPE to acquire a high value biotechnology asset because the process is naturally fraught with potential pitfalls, and as anouther poster pointed out, they can’t raise everyone’s hopes too high in case something goes wrong.
i know you don’t trust promises of hope and trust right now but I would urge you to look at the alternatives, when and IF they become available, and ask yourself what you see the company looking like in the next few years time?
A company with a biotechnological asset (if not this asset then some other biotech asset), with possible FDA approval to go ahead with commercial initiatives...
or......?
i want the best for FTT (and I hope to have the funds to be able to invest in it) AND it’s BOD, and I just know they can have the capability of delivering a bright future for FTT and it’s shareholders.
justaguess
FTT Price at posting:
0.3¢ Sentiment: Buy Disclosure: Not Held
